Beckmann R, Geiger M, Binder B R
Department of Medical Physiology, University of Vienna, Austria.
J Biol Chem. 1988 May 25;263(15):7176-80.
Plasminogen activation by tissue-type plasminogen activator (t-PA) is stimulated by fibrin. In a purified system maximal fibrin-enhanced plasmin formation occurs with a delay after an initial phase of slow plasmin formation (lag phase). In the present study purified stimulating CNBr-fragment FCB-2 of fibrinogen was used, and kinetics of plasminogen activation by t-PA were analyzed with respect to the lag phase. At constant FCB-2 concentration the duration of the lag phase decreased with increasing concentrations of t-PA and plasminogen. During this period the rate of plasmin formation/min increased linearly with time with a slope dependent on the initial concentrations of FCB-2, plasminogen, and t-PA. Plasmin pretreatment of FCB-2 resulted in a dose- and time-dependent shortening of the lag phase, and at plasmin concentrations greater than or equal to 1 nM and preincubation times greater than or equal to 3 min maximal plasmin formation occurred without a lag phase. Kinetics during the phase of maximal and constant plasmin formation were not influenced by plasmin pretreatment of FCB-2. We therefore conclude that maximal t-PA-dependent plasmin formation in a system stimulated by purified FCB-2 requires plasmin modification of FCB-2.
组织型纤溶酶原激活物(t-PA)介导的纤溶酶原激活作用受纤维蛋白刺激。在纯化系统中,纤维蛋白增强的纤溶酶形成在缓慢纤溶酶形成的初始阶段(延迟期)后出现延迟,并达到最大值。在本研究中,使用了纯化的纤维蛋白原溴化氰片段FCB-2,并针对延迟期分析了t-PA激活纤溶酶原的动力学。在FCB-2浓度恒定的情况下,延迟期的持续时间随t-PA和纤溶酶原浓度的增加而缩短。在此期间,每分钟纤溶酶形成速率随时间呈线性增加,其斜率取决于FCB-2、纤溶酶原和t-PA的初始浓度。用纤溶酶预处理FCB-2会导致延迟期呈剂量和时间依赖性缩短,当纤溶酶浓度大于或等于1 nM且预孵育时间大于或等于3分钟时,纤溶酶形成达到最大值且无延迟期。在纤溶酶形成最大值和恒定值阶段的动力学不受FCB-2纤溶酶预处理的影响。因此,我们得出结论,在纯化的FCB-2刺激的系统中,最大程度的t-PA依赖性纤溶酶形成需要FCB-2的纤溶酶修饰。